Cargando…

Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. It is characterized by a wide spectrum of hepatic changes, which may progress to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFLD is considered a hepatic manifestation of metabolic syndrome; however, mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Yinhua, Zhuge, Fen, Nagashimada, Mayumi, Ota, Tsuguhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963867/ https://www.ncbi.nlm.nih.gov/pubmed/27347998 http://dx.doi.org/10.3390/nu8070391

Ejemplares similares

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
por: Xu, Liang, et al.
Publicado: (2017)

Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
por: Xu, Liang, et al.
Publicado: (2019)

A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice
por: Xu, Liang, et al.
Publicado: (2018)

Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E
por: Ni, Yinhua, et al.
Publicado: (2015)

Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
por: Chen, Guanliang, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
por: Kitade, Hironori, et al.
Publicado: (2017)

Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
por: Xu, Liang, et al.
Publicado: (2015)

Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics
por: Nagashimada, Mayumi, et al.
Publicado: (2021)

Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E
por: Kobori, Masuko, et al.
Publicado: (2017)

Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E
por: Kobori, Masuko, et al.
Publicado: (2017)

β-Cryptoxanthin Alleviates Diet-Induced Nonalcoholic Steatohepatitis by Suppressing Inflammatory Gene Expression in Mice
por: Kobori, Masuko, et al.
Publicado: (2014)

Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction
por: Xu, Liang, et al.
Publicado: (2019)

Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice
por: Nishikawa, Tomoki, et al.
Publicado: (2020)

LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH
por: Takata, Noboru, et al.
Publicado: (2021)

Health Benefits of Carotenoids: A Role of Carotenoids in the Prevention of Non-Alcoholic Fatty Liver Disease
por: Lee, Yoojin, et al.
Publicado: (2019)

Carotenoids in orange carrots mitigate non-alcoholic fatty liver disease progression
por: Balbuena, Emilio, et al.
Publicado: (2022)

Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile, and Macrophage Polarization
por: Du, Yong, et al.
Publicado: (2021)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

The Potential of Non-Provitamin A Carotenoids for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
por: Murillo, Ana Gabriela, et al.
Publicado: (2016)

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
por: Thibaut, Ronan, et al.
Publicado: (2021)

Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003–2014
por: Christensen, Krista, et al.
Publicado: (2019)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

CCR5 Plays a Critical Role in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Both Macrophage Recruitment and M1/M2 Status
por: Kitade, Hironori, et al.
Publicado: (2012)

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)

The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
por: Kohlhepp, Marlene Sophia, et al.
Publicado: (2023)

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
por: Martínez–Sánchez, Celia, et al.
Publicado: (2023)

Bmal1 Regulates Macrophage Polarize Through Glycolytic Pathway in Alcoholic Liver Disease
por: Zhou, Yiwen, et al.
Publicado: (2021)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Contribution of Macrophage Efferocytosis to Liver Homeostasis and Disease
por: Horst, Andrea Kristina, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Regulation of PPAR-γ activity in lipid-laden hepatocytes affects macrophage polarization and inflammation in nonalcoholic fatty liver disease
por: Li, Xiao-Yun, et al.
Publicado: (2022)

Macrophage Polarization and Liver Ischemia-Reperfusion Injury
por: Wang, Hai, et al.
Publicado: (2021)

Macrophage Polarization and Its Role in Liver Disease
por: Wang, Cheng, et al.
Publicado: (2021)

Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease
por: Fukushima, Hisataka, et al.
Publicado: (2020)

Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)
por: Kragh Petersen, Sine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h8bntht3tf3brhj1ml48b8m9fv